期刊文献+

奇迹束丝放线菌合成安丝菌素过程中支链氨基酸的添加效果分析 被引量:7

Effects Analysis of Adding Branched Amino Acids on the Biosynthesis of Ansamitocins by Actinosynnema mirum
下载PDF
导出
摘要 安丝菌素是一类重要的聚酮抗生素,由AP-1,AP-2,AP-3,AP-3′和AP-4 5个组分组成,其中AP-3的活性最强,通常作为发酵的目标产物。奇迹束丝放线菌合成安丝菌素的摇瓶实验发现,添加支链氨基酸(BCAAs)可明显影响安丝菌素的产量以及组分。为了进一步验证支链氨基酸对安丝菌素生物合成的作用,选用合成培养基并在不同时段添加支链氨基酸进行发酵实验,实验结果显示,发酵48h后加入0.5g/L缬氨酸(Val)能使AP-3增产1倍左右;而在同一时刻添加等量的亮氨酸(Leu)和异亮氨酸(Ile)对AP-3的抑制作用较明显,产量分别下降了58.8%和83.3%,且添加Leu和Ile分别使得AP-4与AP-2组分增加。此外,添加Ile可使琥珀酸与乙酸的积累量都明显上升,而添加Val使得细胞分泌琥珀酸和乙酸明显变少,这意味着奇迹束丝放线菌代谢支链氨基酸不仅影响对聚酮途径以及侧链合成,对细胞的代谢状态也有一定影响。 Ansamitocins are a group of macrolide antibiotics, which include five components, i. e. , AP-1, AP-2, AP-3, AP-3' and AP-4. Among these components, AP-3 is an active and potent antitumor maytansinoid, which is also the target fermentation product. The yield and composition of ansamitocins by Actinosynnema mirum were observed to be significantly affected by the addition of branched chain amino acids (BCCAs). Experiment results showed that the AP-3 yield has doubled with the supplementation of 0.5 g/L valine at 48 h of fermentation, while adding 0.5 g/L leucine or isoleucine exhibited significant inhibition on AP-3 yield (decreased by 58.8% or 83.3G, respectively). Instead, the contents of AP-2 and AP-4 were increased when leucine or isoleucine was added into the medium. In addition, the secretion of sucelnle that and the side acid and acetic acid was reduced with the addition of valine but increased by isoleucine, implying metabolism of BCCAs in Actinosynnema. mirum influences not only the synthesis of polyketone chains, but also the metabolic state of cells.
出处 《华东理工大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第6期675-680,712,共7页 Journal of East China University of Science and Technology
基金 国家重点实验室专项经费(2060204) 上海市重点学科建设项目(B505)
关键词 安丝菌素 AP-3合成 奇迹束丝放线菌 支链氨基酸 有机酸 ansamitocins AP-3 production Actinosynnema rnirurn~ branched chain amino acids(BCAAs) organic acids
  • 相关文献

参考文献14

  • 1Higashide E, Asai M, Ootsu K, et al , Ansamirccin , a group of novel rnayt ansinoid antibiotics with antitumour properties from Nocardia[J].Journal of Systematic Bacteriology, 1977, 28(2), 304-310.
  • 2Hatano K, Mizuta E, Akiyama Sl' et a l . Biosyntheric origin of the ansa-structure of ansamitocin P-3[J]. Agricultural and Biological Chemistry, 1985,49(2),327-333.
  • 3Moore 13 S, Hertweck C. Biosynthesis and attachment of no?vel bacterial polyketide synthase starter units[J]. Natural Product Reports. 2002. 19(1), 70-99.
  • 4Denoya C D. Fedechko R W, Hafner E W, et al . A second branched-chain alpha-keto acid dehydrogenase gene cluster (bkdFGH) from St re ptom yces a-uermit.ilis Its relationship to avermectin biosynthesis and the construction of a hkdF mu?tant suitable for the production of novel antiparasitic avermec?tins[J].Journal of Bacteriology, 1995. 177 (12), 3504- 3511.
  • 5Stirrett K. Denoya C, Westphe1ingJ. Branched-chain amino acid catabolism provides precursors for the type II polyketide antibiotic , act inorhodin , via pathways that arc nutrient de?pendent[J]'Journal of lndustria1 Microbiology &. Bio?technology, 2009,36(1): 129-137.
  • 6Watanabe K. Actino:;ynnema mi ru m , a new producer of nocardicin antibiotics[J].Journal of Antibiotics, 1983, 36 (3): 321-324.
  • 7Yu Tinwein , Bai Linquan , Clade Dorothee , et al . The bio?synt het ic gene cluster of the mayt ansinoid antitumor agent ansarnitocin from Act inns ynnema pret iosum[J]. Proceedings of the National Academy of Sciences, Z002. 99 ( 12): 7968-? 7973.
  • 8Lio1ios K, Mavrornat is K. Tavemarakis N, et al. The Ge?nomes On Line Database (GOLD) in 2007: Status of genomic and metagenomic projects and their associated metadata[J]. Nucleic Acids Research, 2008. 36( 1): 475-479.
  • 9LinJ in xia , Bai Linquan , Deng Zixin , et al . Effect of ammo?nium in medium on ansarnitocin P-3 production by Actinosyn?uema pret iosicm[J]. Biotechnology and Bioprocess Engineer- ing , 2010, ISO): 119-125.
  • 10Yao Yuqin , Cheng Zhihui, Yc Haoyu, et at. Preparative iso?lation and purification of antitumor agent a nsarni tocin P-3[rorn fermentation broth of Actinosynnema pretiusurn using high-performance counter-current chromatography[J].J our?nal of Separation Science. 2010.33(9): l:l31-1337.

同被引文献39

  • 1孙建义,翁晓燕.赤霉酸产生菌UF456发酵条件的研究[J].微生物学报,1994,34(6):444-448. 被引量:2
  • 2刘宁,金志华,骆健美,岑沛霖.前体对纳他霉素生物合成的影响[J].中国抗生素杂志,2005,30(6):328-331. 被引量:10
  • 3吕伟,庄英萍,储炬,王永红,张嗣良.氨基酸对利用红色糖多孢菌发酵生产红霉素的产量及组分影响研究[J].中国抗生素杂志,2006,31(10):595-599. 被引量:7
  • 4王彦波,鲜开梅,张永华,刘慧英.赤霉素的应用研究进展[J].北方园艺,2007(6):74-75. 被引量:62
  • 5姚骏骅,刘明.HPLC-ESI/Ms测定安丝菌素同系物[J].质谱学报,2008,27:108-109.
  • 6ERICKSON H K,LAMBERT J M.ADME of antibody-maytansi- noid conjugates [J ].The APPS Journal, 2012,14 ( 4 ) : 799-805.
  • 7WHITEMAN K R,JOHNSON H A,MAYO M F, et al. Lorvo- tuzumab mertansine,a CD56-targeting mltibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models[J], mAbs, 2014,6(2):556-566.
  • 8丁靖志,倪穗佳,孟锐奇,等.生产安丝菌素的发酵培养基[P].中国专利:CN103255184A,2013-08-21.
  • 9Cihangir N. Stimulation of the gibberellic acid synthesis by Aspergillus niger in submerged culture using a precursor EJ]. WorldJMicrobiol Biotechnol, 2002, 18 (8) : 727--729.
  • 10Tudzynski B. Gibberellin biosynthesis in tiangl: genes, enzymes, evolution, and impact on biotechnology [J]. Appl Microbiol Biotechnol, 2005, 66 (6) : 597--611.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部